Literature DB >> 10221768

The p38 mitogen-activated protein kinase cascade is not required for the stimulation of insulin secretion from rat islets of Langerhans.

C J Burns1, S L Howell, P M Jones, S J Persaud.   

Abstract

The expression of the p38 subfamily of mitogen-activated protein kinases (MAPKs) was examined in rat islets of Langerhans and pancreatic beta-cell lines, and its involvement in the regulation of insulin secretion was investigated. Rat islets and several rodent beta-cell lines were shown to express p38 MAPK by Western blotting. The cellular stress agents sodium arsenite and hyperosmotic sorbitol significantly stimulated p38 MAPK activity, as did the tyrosine phosphatase inhibitor sodium pervanadate and the serine/threonine phosphatase inhibitor okadaic acid. Increases in p38 MAPK activity were not consistently correlated with increases in insulin secretion, and the dissociation between p38 MAPK activity and the regulation of insulin secretion was further demonstrated in studies using the specific p38 MAPK inhibitor SB203580, which was without significant effect on the stimulation of insulin secretion by glucose, 4beta phorbol myristate acetate and forskolin. These studies indicate that although p38 MAPK is expressed in pancreatic beta-cells and can be activated pharmacologically, its activity can be dissociated from the exocytotic release of insulin from rat islets of Langerhans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221768     DOI: 10.1016/s0303-7207(98)00239-1

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

1.  The permissive effects of glucose on receptor-operated potentiation of insulin secretion from mouse islets: a role for ERK1/2 activation and cytoskeletal remodelling.

Authors:  J E Bowe; A Chander; B Liu; S J Persaud; P M Jones
Journal:  Diabetologia       Date:  2013-01-24       Impact factor: 10.122

2.  Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats.

Authors:  Jantira Sanit; Eakkapote Prompunt; Punyanuch Adulyaritthikul; Nuttikarn Nokkaew; Podsawee Mongkolpathumrat; Kantapich Kongpol; Anusak Kijtawornrat; Soontaree Petchdee; Stephanie Barrère-Lemaire; Sarawut Kumphune
Journal:  Exp Ther Med       Date:  2019-07-10       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.